
Excessive sweating affects 1-5% of the population and can have a substantial impact on quality of life

A record two million women were prescribed hormone replacement therapy in 2025/26 compared to 0.8 million in 2020/21

Against the backdrop of widespread medicine shortages, Durbin PLC’s rebrand to Uniphar and integration into Uniphar | Global Sourcing represents a strategic move to address industry-wide challenges, expanding its sourcing...

This is the first approved treatment option in the UK for patients with non-segmental vitiligo

US tariffs on UK-produced pharmaceuticals will remain at zero for three years

The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales

The Commission will unite healthcare leaders, regulators and technology experts to shape future AI governance

More than 11,000 people are diagnosed with head and neck cancers every year in England

Approximately 600 people are affected by the form of non-Hodgkin lymphoma every year in the UK

Discover how patient personas can revolutionise clinical trial recruitment and retention. Personalise outreach, build trust, and improve patient engagement.

The plan’s three overarching themes are hospital to community, analogue to digital and sickness to prevention

The once-a-day drug has been recommended for patients with a history of previous medical or surgical treatment